Evidence map›Paper›PMID 33829643›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2021

Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates.

Dibyadeep Datta, Shannon N Leslie, Min Wang, Yury M Morozov, Shengtao Yang, SueAnn Mentone, Caroline Zeiss, Alvaro Duque, Pasko Rakic, Tamas L Horvath and 3 more

Open access · greenAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Genomic and proteomic conversion of brain ischemia to Alzheimer's disease.Frontiers in cell and developmental biology · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Dibyadeep DattaDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Shannon N LeslieDepartment of Psychiatry, School of Medicine, Yale University, Connecticut, USA.
Min WangDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Yury M MorozovDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Shengtao YangDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
SueAnn MentoneDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Caroline ZeissDepartment of Comparative Medicine, School of Medicine, Yale University, Connecticut, USA.
Alvaro DuqueDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Pasko RakicDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Tamas L HorvathDepartment of Comparative Medicine, School of Medicine, Yale University, Connecticut, USA.
Christopher H van DyckDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Angus C NairnDepartment of Psychiatry, School of Medicine, Yale University, Connecticut, USA.
Amy F T ArnstenDepartments of Neuroscience, School of Medicine, Yale University, Connecticut, USA.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI Heather Gwynn Allore · 2020 to 2026
$30.2M
Interdepartmental Neuroscience Program (INP)T32NS041228 · NINDS · YALE UNIVERSITY · PI Charles A Greer, Marina R Picciotto · 2001 to 2026
$12.0M
Yale Alzheimer Disease Research CenterP50AG047270 · NIA · YALE UNIVERSITY · PI MAROTTOLI, RICHARD · 2015 to 2019
$8.3M
Origin of Cortical Species-specific Distinctions.R01DA023999 · NIDA · YALE UNIVERSITY · PI RAKIC, PASKO · 2008 to 2019
$7.9M
Origin of Cortical Species-specific DistinctionsR37DA023999 · NIDA · YALE UNIVERSITY · PI PASKO RAKIC · 2020 to 2026
$5.6M
Yale Macaque Brain ResourceR01MH113257 · NIMH · YALE UNIVERSITY · PI Alvaro Duque · 2017 to 2026
$4.3M
Preclinical assessment of GCPII inhibitors for cognition and tau pathologyR01AG061190 · NIA · YALE UNIVERSITY · PI ARNSTEN, AMY F.T. · 2019 to 2023
$4.2M
Highly evolved brain circuits in primates: molecular vulnerabilities for diseaseDP1AG047744 · NIA · YALE UNIVERSITY · PI ARNSTEN, AMY F.T. · 2013 to 2017
$4.1M
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery ProgramR01AG062306 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI ARNOLD, STEVEN E, CARLYLE, BECKY CATHERINE · 2018 to 2022
$3.5M
PET imaging of AD-related markers in non-human primatesR01AG052986 · NIA · YALE UNIVERSITY · PI HORVATH, TAMAS L, LAWRENCE, MATTHEW SWAN · 2017 to 2020
$2.9M
In vivo and in vitro systems to validate geronic proteins and their mechanisms of actionR56AG052986 · NIA · YALE UNIVERSITY · PI HORVATH, TAMAS L, LAWRENCE, MATTHEW SWAN · 2016 to 2016
$494k
NCATS NIH HHS UL1 TR001863NIA NIH HHS DP1 AG047744NIA NIH HHS F31 AG063425NIA NIH HHS P30 AG066508NIA NIH HHS P50 AG047270NIA NIH HHS R01 AG052986NIA NIH HHS R01 AG061190NIA NIH HHS R01 AG062306NIA NIH HHS R56 AG052986NIDA NIH HHS R01 DA023999NIDA NIH HHS R37 DA023999NIMH NIH HHS R01 MH113257NINDS NIH HHS T32 NS041228
6 · The paper itself

Abstract

introductionThe etiology of sporadic Alzheimer's disease (AD) requires non-genetically modified animal models.

methodsThe relationship of tau phosphorylation to calcium-cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) dysregulation was analyzed in aging rhesus macaque dorsolateral prefrontal cortex (dlPFC) and rat primary cortical neurons using biochemistry and immuno-electron microscopy. The influence of calcium leak from ryanodine receptors (RyRs) on neuronal firing and cognitive performance was examined in aged macaques.

resultsAged monkeys naturally develop hyperphosphorylated tau, including AD biomarkers (AT8 (pS202/pT205) and pT217) and early tau pathology markers (pS214 and pS356) that correlated with evidence of increased calcium leak (pS2808-RyR2). Calcium also regulated early tau phosphorylation in vitro. Age-related reductions in the calcium-binding protein, calbindin, and in phosphodiesterase PDE4D were seen within dlPFC pyramidal cell dendrites. Blocking RyRs with S107 improved neuronal firing and cognitive performance in aged macaques. DISCUSSION: Dysregulated calcium signaling confers risk for tau pathology and provides a potential therapeutic target.

Indexed as

Macaca mulattaAgingAnimalsCalciumCalcium SignalingCognitive DysfunctionCyclic AMP-Dependent Protein KinasesDisease Models, AnimalHumansMaleNeuronsPhosphorylationPrefrontal CortexRatsRyanodine Receptor Calcium Release Channeltau ProteinsCalciumCyclic AMP-Dependent Protein KinasesRyanodine Receptor Calcium Release Channeltau Proteinsagingassociation cortexcalpainimpaired cognitionmacaquePKApyramidal cellsryanodine receptortau

Identifiers

PMID33829643
PMCPMC8195842
OpenAlexW3141097240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.